Sinopharm Lanzhou Vaccine Production Base Project


Customer


Sinopharm

Location


Lanzhou,China

Overview

The polysaccharide-conjugate protein vaccine project of Lanzhou Institute of Biological Products (Sinopharm) covers an area of ​​approximately 14,909 square meters and has a total construction area of ​​approximately 63,343 square meters. The production workshop after completion achieves an annual output of 10 million doses of quadrivalent meningococcal conjugate vaccine, 25 million doses of 13-valent pneumococcal conjugate vaccine, and 30 million doses of typhoid polysaccharide-protein conjugate vaccine.

Our Solution

HUBER & RANNER supplied combined supply/exhaust AHU units to many biological product research institutes under China Biologic, totalling more than 600 units. Their stable and reliable operation has been recognized by customers.

Design Points

Run-around coil-type energy recovery system (KVS EDS);
Built-in high-voltage electrical supply cabinet;
Low-temperature cold storage units with enhanced thermal insulation.

Diese Website verwendet Cookies.
Wir verwenden Cookies, um Inhalte und Anzeigen zu personalisieren, Funktionen für soziale Medien anbieten zu können und die Zugriffe auf unsere Website zu analysieren.
Project Quotation
Subscribe to our newsletter

Cookie Settings

STRICTLY NECESSARY (Mandatory)

These cookies are mandatory and you cannot refuse them. They ensure the stability and the correct and safe functioning of the service. Example: Authentication cookies, security cookies, multimedia player session cookies, load balancing cookies, “user-input” cookies, preferences settings.

CUSTOMIZED EXPERIENCE & MARKETING (Optional)

Targeting cookies collect users’ information and use it to build a profile of users' interests to show personalized content for that specific user. They are usually shared among partners and follow the user on multiple websites.